Cwm LLC Has $161,000 Stake in DaVita Inc. (NYSE:DVA)

Cwm LLC boosted its holdings in DaVita Inc. (NYSE:DVA) by 36.9% in the 4th quarter, HoldingsChannel.com reports. The firm owned 1,537 shares of the company’s stock after acquiring an additional 414 shares during the quarter. Cwm LLC’s holdings in DaVita were worth $161,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also bought and sold shares of the business. State of Michigan Retirement System lifted its stake in shares of DaVita by 0.6% in the fourth quarter. State of Michigan Retirement System now owns 15,939 shares of the company’s stock valued at $1,670,000 after buying an additional 100 shares in the last quarter. Treasurer of the State of North Carolina lifted its position in DaVita by 0.5% in the 3rd quarter. Treasurer of the State of North Carolina now owns 24,503 shares of the company’s stock valued at $2,316,000 after acquiring an additional 123 shares in the last quarter. Daiwa Securities Group Inc. boosted its stake in DaVita by 3.2% during the 3rd quarter. Daiwa Securities Group Inc. now owns 4,631 shares of the company’s stock valued at $438,000 after purchasing an additional 144 shares during the last quarter. PNC Financial Services Group Inc. increased its holdings in DaVita by 1.0% during the 3rd quarter. PNC Financial Services Group Inc. now owns 15,088 shares of the company’s stock worth $1,426,000 after purchasing an additional 153 shares in the last quarter. Finally, New Mexico Educational Retirement Board raised its stake in shares of DaVita by 7.4% in the third quarter. New Mexico Educational Retirement Board now owns 2,886 shares of the company’s stock worth $273,000 after purchasing an additional 200 shares during the last quarter. Institutional investors own 90.12% of the company’s stock.

DaVita Stock Down 5.5 %

DaVita stock opened at $134.45 on Friday. The company has a quick ratio of 1.13, a current ratio of 1.19 and a debt-to-equity ratio of 6.65. The company has a market capitalization of $11.79 billion, a P/E ratio of 15.28, a P/E/G ratio of 1.27 and a beta of 1.04. The firm has a 50 day moving average price of $133.71 and a 200-day moving average price of $112.59. DaVita Inc. has a twelve month low of $71.51 and a twelve month high of $145.04.

DaVita (NYSE:DVA) last posted its quarterly earnings results on Thursday, May 2nd. The company reported $2.38 earnings per share for the quarter, topping the consensus estimate of $1.95 by $0.43. The company had revenue of $3.07 billion during the quarter, compared to the consensus estimate of $3.03 billion. DaVita had a return on equity of 66.59% and a net margin of 6.61%. The firm’s quarterly revenue was up 6.9% compared to the same quarter last year. During the same quarter in the prior year, the company earned $1.58 EPS. As a group, equities analysts predict that DaVita Inc. will post 9.23 EPS for the current year.

Insiders Place Their Bets

In related news, insider James O. Hearty sold 26,164 shares of the company’s stock in a transaction that occurred on Friday, February 16th. The shares were sold at an average price of $119.64, for a total transaction of $3,130,260.96. Following the sale, the insider now owns 20,264 shares of the company’s stock, valued at approximately $2,424,384.96. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. In other DaVita news, COO Michael David Staffieri sold 29,488 shares of the firm’s stock in a transaction dated Wednesday, February 21st. The stock was sold at an average price of $119.81, for a total value of $3,532,957.28. Following the sale, the chief operating officer now owns 37,687 shares of the company’s stock, valued at approximately $4,515,279.47. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, insider James O. Hearty sold 26,164 shares of the business’s stock in a transaction dated Friday, February 16th. The stock was sold at an average price of $119.64, for a total value of $3,130,260.96. Following the transaction, the insider now directly owns 20,264 shares of the company’s stock, valued at approximately $2,424,384.96. The disclosure for this sale can be found here. Insiders sold a total of 134,540 shares of company stock worth $16,551,071 in the last quarter. 1.40% of the stock is owned by company insiders.

Wall Street Analyst Weigh In

DVA has been the subject of a number of analyst reports. Barclays initiated coverage on DaVita in a research report on Wednesday, March 6th. They issued an “equal weight” rating and a $133.00 price target for the company. TheStreet raised shares of DaVita from a “c+” rating to a “b-” rating in a research report on Wednesday, February 7th. StockNews.com raised shares of DaVita from a “buy” rating to a “strong-buy” rating in a research report on Thursday, April 25th. Truist Financial lifted their target price on shares of DaVita from $130.00 to $135.00 and gave the stock a “hold” rating in a research report on Tuesday, February 20th. Finally, UBS Group upped their target price on DaVita from $113.00 to $134.00 and gave the company a “buy” rating in a report on Wednesday, February 14th. Two research analysts have rated the stock with a hold rating, one has issued a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $118.50.

About DaVita

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.